Enveda
Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.
$311MSeries E
ParticipantI
ICONIQ
Activity from announced rounds
Activity in this selectionOct 16, 2026 · Jul 19, 2026
- Rounds participated in
- 5
- Confirmed lead rounds
- 0 3 roles undisclosed
- New companies
- 5 First participation on record · 0 follow-on
- Funding in participating rounds
- $1.2B 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
5 in this selectionMedici Brands
Medici Brands builds and scales consumer food brands including David protein bars, shakes and frozen desserts, HallPass confectionery, and Epogee, a plant-based fat ingredient.
$250MSeries B
ParticipantRillet
AI-native ERP platform where finance teams and AI agents run accounting together
$100MSeries C
Role not disclosedK2 Space
Manufactures large, high-power satellites.
$500MSeries D
Role not disclosedPaper
Design platform for the agentic era, enabling designers and engineers to collaborate through a shared language.
$34MSeries A
Role not disclosed